WCN26-3786 A CASE OF CBL SYNDROME WITH ANTI-NEPHRIN ANTIBODY POSITIVE NEPHROTIC SYNDROME SUCCESSFULLY TREATED WITH RITUXIMAB

Read full text Summarise with VIRAT
Authors: Natsumi Inoue, Tadafumi Yokoyama, Norifumi Hayashi, Kengo Furuichi, Ryoko Akai, Takao Iwawaki, Taizo Wada
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

CBL syndrome, caused by germline mutations in the CBL gene, is classified as a RASopathy and is characterized by Noonan-like features, juvenile myelomonocytic leukemia (JMML) predisposition, autoimmunity, and developmental delay. Although abnormalities in the RAS/MAPK pathway underlie the pathogenesis of RASopathies, reports of immune-mediated kidney disease associated with RASopathies are rare, and its mechanisms remain unclear. Here we report a pediatric case of CBL syndrome complicated by steroid-resistant nephrotic syndrome (SRNS), in whom circulating anti-nephrin antibodies were detected.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Immunodeficiency and Autoimmune Disorders Vasculitis and related conditions

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105600–105600
Publication date
25 March 2026
Language
EN